These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11101184)

  • 21. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus].
    Rosas Vargas MA; Alvarez Amador M; Alvarez Amador LM; del Río Navarro BE; Avila Castanón L; Sienra Monge JJ
    Rev Alerg Mex; 2001; 48(5):129-32. PubMed ID: 11759253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin.
    Sola-Gazagnes A; Pecquet C; Radermecker R; Piétri L; Elgrably F; Slama G; Sélam JL
    Diabetes Care; 2003 Oct; 26(10):2961-2. PubMed ID: 14514615
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine.
    Petrovski G; Zivkovic M; Milenkovic T; Ahmeti I; Bitovska I
    Acta Diabetol; 2014 Dec; 51(6):1073-5. PubMed ID: 24811944
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
    Kapellen TM; Klinkert C; Heidtmann B; Jakisch B; Haberland H; Hofer SE; Holl RW
    Postgrad Med; 2010 May; 122(3):98-105. PubMed ID: 20463419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin pump treatment of type I diabetes mellitus in a patient with C6 quadriplegia.
    Barlascini CO; Schmitt JK; Adler RA
    Arch Phys Med Rehabil; 1989 Jan; 70(1):58-60. PubMed ID: 2916920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin pump therapy and rapid acting insulin: what have we learned?
    Zinman B
    Int J Clin Pract Suppl; 2001 Sep; (123):47-50. PubMed ID: 11594299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin lispro: new preparation. Faster acting.
    Prescrire Int; 1998 Jun; 7(35):67-8. PubMed ID: 10342918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.
    Danne T
    Clin Ther; 2007; 29 Suppl D():S145-52. PubMed ID: 18191066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion.
    Moyes V; Driver R; Croom A; Mirakian R; Chowdhury TA
    Diabet Med; 2006 Feb; 23(2):204-6. PubMed ID: 16433720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin allergy: an approach to therapy.
    Bucholtz HK
    South Med J; 1976 Sep; 69(9):1118-20. PubMed ID: 135348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
    Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
    An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic tolerance to intravenously injected insulin.
    Asai M; Yoshida M; Miura Y
    N Engl J Med; 2006 Jan; 354(3):307-9. PubMed ID: 16421379
    [No Abstract]   [Full Text] [Related]  

  • 36. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
    Nagai T; Nagai Y; Tomizawa T; Mori M
    Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic allergy to endogenous insulin during therapy with recombinant DNA (rDNA) insulin.
    Alvarez-Thull L; Rosenwasser LJ; Brodie TD
    Ann Allergy Asthma Immunol; 1996 Mar; 76(3):253-6. PubMed ID: 8634879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.
    Fineberg SE; Huang J; Brunelle R; Gulliya KS; Anderson JH
    Diabetes Care; 2003 Jan; 26(1):89-96. PubMed ID: 12502663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperpigmentation due to insulin allergy.
    Neki NS; Gupta SN; Mani T; Gupta H
    Natl Med J India; 2014; 27(3):183. PubMed ID: 25668097
    [No Abstract]   [Full Text] [Related]  

  • 40. Type I allergy to insulin: case report and review of localized and systemic reactions to insulin.
    Hoffman AG; Schram SE; Ercan-Fang NG; Warshaw EM
    Dermatitis; 2008; 19(1):52-8. PubMed ID: 18346398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.